(Q36174526)

12 August 2017

1 reference

title

Drug treatment of pulmonary arterial hypertension: current and future agents (English)

1 reference

12 August 2017

main subject

arterial hypertension

1 reference

Marius M Hoeper

1

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

65

1 reference

12 August 2017

issue

10

1 reference

12 August 2017

page(s)

1337-1354

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565100-00003

12 August 2017

exact match

0 references

cites work

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

1 reference

12 December 2020

Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease

1 reference

12 December 2020

Bosentan and warfarin interaction

1 reference

12 December 2020

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study

1 reference

12 December 2020

Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy.

1 reference

12 December 2020

Pulmonary Veno-occlusive Disease

1 reference

12 December 2020

Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects

1 reference

12 December 2020

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension

1 reference

12 December 2020

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

1 reference

12 December 2020

Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease

1 reference

12 December 2020

Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension

1 reference

12 December 2020

Tadalafil in primary pulmonary arterial hypertension

1 reference

12 December 2020

Prostanoid therapy for pulmonary arterial hypertension.

1 reference

12 December 2020

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

12 December 2020

Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: a case of pulmonary capillary hemangiomatosis

1 reference

12 December 2020

Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension

1 reference

12 December 2020

A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.

1 reference

12 December 2020

Combination therapy for pulmonary arterial hypertension: still more questions than answers

1 reference

12 December 2020

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

1 reference

12 December 2020

Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

1 reference

12 December 2020

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.

1 reference

12 December 2020

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

1 reference

12 December 2020

Diagnosis and differential assessment of pulmonary arterial hypertension

1 reference

12 December 2020

Inhaled iloprost for severe pulmonary hypertension

1 reference

12 December 2020

End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives

1 reference

12 December 2020

Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.

1 reference

12 December 2020

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

12 December 2020

Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension.

1 reference

12 December 2020

Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension

1 reference

12 December 2020

Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats

1 reference

12 December 2020

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

1 reference

12 December 2020

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

12 December 2020

Improving survival in pulmonary arterial hypertension.

1 reference

12 December 2020

Chronic oral sildenafil therapy in severe pulmonary artery hypertension.

1 reference

12 December 2020

Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

1 reference

12 December 2020

Endothelin and pulmonary hypertension

1 reference

12 December 2020

Orally active prostacyclin analogue in primary pulmonary hypertension

1 reference

12 December 2020

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension

1 reference

12 December 2020

Initial experience with bosentan therapy in patients with the Eisenmenger syndrome

1 reference

12 December 2020

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

1 reference

12 December 2020

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

1 reference

12 December 2020

Sildenafil improves right-ventricular parameters and quality of life in primary pulmonary hypertension

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

1 reference

12 December 2020

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

12 December 2020

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

1 reference

12 December 2020

Ambrisentan (Myogen).

1 reference

12 December 2020

Sitaxsentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Pilot Intervention: Aerosolized Adrenomedullin Reduces Pulmonary Hypertension

1 reference

12 December 2020

Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues.

1 reference

12 December 2020

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

12 December 2020

Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results

1 reference

12 December 2020

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Treatment of HIV-associated pulmonary hypertension with treprostinil

1 reference

12 December 2020

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells

1 reference

12 December 2020

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension

1 reference

12 December 2020

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

1 reference

12 December 2020

Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation

1 reference

12 December 2020

Chronic thromboembolic pulmonary hypertension

1 reference

12 December 2020

Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension

1 reference

12 December 2020

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

1 reference

12 December 2020

Beraprost therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels

1 reference

12 December 2020

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension

1 reference

12 December 2020

Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol

1 reference

12 December 2020

Pathogenesis of HIV-related pulmonary hypertension.

1 reference

12 December 2020

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

1 reference

12 December 2020

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

1 reference

12 December 2020

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

1 reference

12 December 2020

Differential adrenomedullin release and endothelin receptor expression in distinct subpopulations of human airway smooth-muscle cells.

1 reference

12 December 2020

1 reference

12 December 2020

Portopulmonary hypertension and hepatopulmonary syndrome

1 reference

12 December 2020

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series

1 reference

12 December 2020

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

12 December 2020

Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.

1 reference

12 December 2020

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

1 reference

12 December 2020

New treatments for pulmonary arterial hypertension

1 reference

12 December 2020

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

1 reference

12 December 2020

Increased plasma serotonin in primary pulmonary hypertension

1 reference

12 December 2020

Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades

1 reference

12 December 2020

Pulmonary arterial hypertension in congenital heart disease

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension

1 reference

12 December 2020

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

12 December 2020

Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations.

1 reference

12 December 2020

Pulmonary Hypertension:CT of the Chest in Pulmonary Venoocclusive Disease

1 reference

12 December 2020

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Chronic thromboembolic pulmonary hypertension

1 reference

12 December 2020

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

1 reference

12 December 2020

Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

1 reference

12 December 2020

Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with oral sildenafil

1 reference

12 December 2020

Treprostinil sodium Pharmacia.

1 reference

12 December 2020

Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

12 December 2020

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

1 reference

12 December 2020

Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy

1 reference

12 December 2020

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

12 December 2020

Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.

1 reference

12 December 2020

Sildenafil treatment of primary pulmonary hypertension

1 reference

12 December 2020

Pulmonary vasodilator response to adrenomedullin in patients with pulmonary hypertension

1 reference

12 December 2020

Sildenafil in primary pulmonary hypertension

1 reference

12 December 2020

Bosentan: a dual endothelin receptor antagonist

1 reference

12 December 2020

Attenuation of chronic hypoxic pulmonary hypertension by simvastatin

1 reference

12 December 2020

Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist

1 reference

12 December 2020

Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol

1 reference

12 December 2020

Long-time survival with HIV-related pulmonary arterial hypertension: a case report

1 reference

12 December 2020

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

1 reference

12 December 2020

Pathologic assessment of vasculopathies in pulmonary hypertension

1 reference

12 December 2020

Endothelial dysfunction in the pulmonary vascular bed.

1 reference

12 December 2020

Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.

1 reference

12 December 2020

Pulmonary arterial hypertension: a look to the future.

1 reference

12 December 2020

The new clinical trials on pharmacological treatment in pulmonary arterial hypertension.

1 reference

12 December 2020

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension

1 reference

12 December 2020

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

1 reference

12 December 2020

The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension

1 reference

12 December 2020

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

12 December 2020

Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension

1 reference

12 December 2020

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.

1 reference

12 December 2020

Bosentan therapy for portopulmonary hypertension

1 reference

12 December 2020

Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease

1 reference

12 December 2020

Long-term treatment of pulmonary hypertension with aerosolized iloprost

1 reference

12 December 2020

Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.

1 reference

12 December 2020

Interventional and surgical modalities of treatment for pulmonary arterial hypertension

1 reference

12 December 2020

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

12 December 2020

Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension

1 reference

12 December 2020

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

12 December 2020

Clinical classification of pulmonary hypertension.

1 reference

12 December 2020

Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension

1 reference

12 December 2020

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

1 reference

12 December 2020

Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

1 reference

12 December 2020

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

1 reference

12 December 2020

The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.

1 reference

12 December 2020

Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis

1 reference

12 December 2020

Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

1 reference

12 December 2020

Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure

1 reference

12 December 2020

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

12 December 2020

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

1 reference

12 December 2020

HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study

1 reference

12 December 2020

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

12 December 2020

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

10.2165/00003495-200565100-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1034324460

0 references

1 reference